ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of March 8, 2023
ScieGen's Generic Diltiazem Hydrochloride Receives Approval in the U.S.
ScieGen's Generic Pregabalin Receives Approval in the U.S.
ScieGen Pharma's Generic Pirfenidone Receives Approval in the U.S.
Sciegen Pharms' Generic Lacosamide Receives Approval in the U.S.
Sciegen Pharms' Generic Metformin Hydrochloride Receives Approval in the U.S.
ScieGen Pharma's Generic ValsartanReceives Approval In US
ScieGen Pharma's Generic ValsartanReceives Approval In US
ScieGen Pharma`s Generic Carbidopa;Levodopa Receives Approval in US